Join the Lymphoma Community at SupportGroups.com

You may have noticed some links at this site for SupportGroups.com, a fast-growing collection of support communities at one site.

The site is owned and operated by the same company that owns and operates lymphomainfo.net. It has been established as the central support group destination for several reputable health-oriented sites in their Deep Health Network, including:

MyAddiction.com
PeanutAllergy.com
CyberRecovery.net
ConceivingConcepts.com
EatingDisordersOnline.com

The groups relevant to this site at SupportGroups.com are support groups dedicated to Hodgkin's Lymphoma and support groups dedicated to non-Hodgkin's lymphoma.

You can build your own profile, throw out questions to an active and supportive community, even start an online lymphoma journal. Keep coming to lymphomainfo.net for its broad database of informative articles, intelligent blogs (*wink*), and other resources, but check out supportgroups.com to find a compassionate ear, or to help someone else who needs one.

More Articles

More Articles

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

In a large trial of older, newly diagnosed patients with chronic lymphocytic leukemia (CLL),...

Today’s typical treatments have been unable to cure numerous types of lymphoma, but emerging immunotherapies could provide the key to...

Biotech firm Gilead Sciences Inc. has announced that the first patient has been dosed in a Phase III trial evaluating the safety and efficacy of...

Last week at the 54th American Society of Hematology Annual Meeting and Exposition in Atlanta, researchers out of MD Anderson Cancer Center in...

The results of a pair of long-term survival studies indicate the therapeutic value of BEXXAR (...

A new lab test that can improve survival rates among patients with chronic lymphocytic leukemia (...

Aggressive Non-Hodgkin’s Lymphomas (NHLs) are fast growing cancers (as opposed to indolent cancers). They involve...

A B cell is a type of lymphocyte that produces antibodies to fight infections. These are the most prevalent lymphocytes in the bloodstream and are...

Sitemap